| 351 | 9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE | I40 |
 |
1 |
| 352 | N-[3-(4-CHLOROPHENYL)-1-{N'-CYANO-N-[3-(DIFLUOROMETHOXY)PHENYL]CARBAMIMIDOYL}-4,5-DIHYDRO-1H- PYRAZOL-4-YL]-N-ETHYL-2-HYDROXYACETAMIDE | I9H |
 |
1 |
| 353 | 3-ISOBUTYL-1-METHYLXANTHINE | IBM |
 |
1 |
| 354 | IBUPROFEN | IBP |
 |
1 |
| 355 | 1-{[5-(5-CHLORO-2-THIENYL)ISOXAZOL-3-YL]METHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE | IIA |
 |
1 |
| 356 | 1-{[5-(5-CHLORO-2-THIENYL)ISOXAZOL-3-YL]METHYL}-3-CYANO-N-(1-ISOPROPYLPIPERIDIN-4-YL)-7-METHYL-1H-INDOLE-2-CARBOXAMIDE | IIB |
 |
1 |
| 357 | N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE | IID |
 |
1 |
| 358 | 1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE | IIE |
 |
1 |
| 359 | 1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-N-(4-{2-[(DIMETHYLAMINO)METHYL]-1H-IMIDAZOL-1-YL}-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE | IK8 |
 |
1 |
| 360 | 2-{[(2Z)-5-(1,3-benzodioxol-5-ylmethyl)-8-fluoro-2-imino-2,3-dihydro[1,2,4]triazolo[1,5-c]quinazolin-10-yl]amino}ethanol | IK9 |
 |
1 |
| 361 | (2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine | IM4 |
 |
1 |
| 362 | [4-({[5-BENZYLOXY-1-(3-CARBAMIMIDOYL-BENZYL)-1H-INDOLE-2-CARBONYL]-AMINO}-METHYL)-PHENYL]-TRIMETHYL-AMMONIUM | IMA |
 |
1 |
| 363 | 5,6,7,8-tetrahydro-4~{a}~{H}-quinazoline-2,4-dione | M1Q |
 |
1 |
| 364 | INOSINIC ACID | IMP |
 |
1 |
| 365 | 1-methylethyl 1-thio-beta-D-galactopyranoside | IPT |
 |
1 |
| 366 | IMINO-TRYPTOPHAN | ITR |
 |
1 |
| 367 | 1-(3-carboxypropyl)-1-methylpyrrolidin-1-ium | IVL |
 |
1 |
| 368 | (4bS,6S)-6-methoxy-1,4,6,7,9,10,12,13-octahydro-3H,5H-pyrano[4',3':3,4]pyrido[2,1-i]indol-3-one | IZN |
 |
1 |
| 369 | 2-[(2-nitrophenyl)sulfanyl]acetohydrazide | J4J |
 |
1 |
| 370 | (5S)-6,6-dimethyl-5-[(6R)-8-oxo-6,8-dihydrofuro[3,4-e][1,3]benzodioxol-6-yl]-5,6,7,8-tetrahydro[1,3]dioxolo[4,5-g]isoquinolin-6-ium | J94 |
 |
1 |
| 371 | 6-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-3-carboxamide | JC8 |
 |
1 |
| 372 | 2-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-4-carboxamide | JCW |
 |
1 |
| 373 | 2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoic acid | JMS |
 |
1 |
| 374 | 1-(3-amino-1,2-benzisoxazol-5-yl)-6-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-7-fluoro-1H-indazole-3-carboxamide | JNJ |
 |
1 |
| 375 | 2-[[(3~{S})-2,5-bis(oxidanylidene)pyrrolidin-3-yl]carbamoyl]-4-nitro-benzoic acid | JO2 |
 |
1 |
| 376 | 3-azanyl-2-[[(3~{S})-2,5-bis(oxidanylidene)pyrrolidin-3-yl]carbamoyl]benzoic acid | JO8 |
 |
1 |
| 377 | 2-[[(3~{S})-2,5-bis(oxidanylidene)pyrrolidin-3-yl]carbamoyl]-6-nitro-benzoic acid | JOE |
 |
1 |
| 378 | ~{N}-[(3~{S})-2,5-bis(oxidanylidene)pyrrolidin-3-yl]-3-phenyl-propanamide | JOK |
 |
1 |
| 379 | 5-(1~{H}-1,2,3,4-tetrazol-5-yl)quinolin-8-ol | JX8 |
 |
1 |
| 380 | N-[3-(tert-butylamino)propyl]-3-(trifluoromethyl)benzamide | K6M |
 |
1 |
| 381 | 18-carboxymethoxy-cleaviminium | KJE |
 |
1 |
| 382 | (2R)-2-hydroxy-N,N,N-trimethyl-2-phosphonoethan-1-aminium | KVP |
 |
1 |
| 383 | N6-benzyl-(alpha,beta)-methylene-ADP | KYK |
 |
1 |
| 384 | (N6,N6)-methyl,benzyl-C2-chloro-(alpha,beta)-methylene-ADP | KYW |
 |
1 |
| 385 | (2R,4S)-N^1^-(4-chlorophenyl)-4-(2,4-difluorophenyl)-4-hydroxy-N^2^-(2-oxo-2H-1,3'-bipyridin-6'-yl)pyrrolidine-1,2-dicarboxamide | L1C |
 |
1 |
| 386 | (2R,4S)-N^1^-(4-chlorophenyl)-N^2^-[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]-4-hydroxy-4-phenylpyrrolidine-1,2-dicarboxamide | L1D |
 |
1 |
| 387 | ethyl (R)-N-[(1E)-1-(diethylamino)ethylidene]phosphonamidate | L1M |
 |
1 |
| 388 | (S)-N-[(1E)-1-(diethylamino)ethylidene]-P-methylphosphonamidic fluoride | L2Y |
 |
1 |
| 389 | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2~{R},3~{S},4~{R},5~{R})-5-[[(1~{E},3~{Z})-5-azanyl-4-oxidanyl-5-oxidanylidene-penta-1,3-dienyl]-methanoyl-amino]-3,4-bis(oxidanyl)oxolan-2-yl]methyl hydrogen phosphate | L3W |
 |
1 |
| 390 | 1-{[(4-cyano-3-cyclopropylphenyl)acetyl]amino}cyclohexane-1-carboxylic acid | L6P |
 |
1 |
| 391 | (~{E})-~{N}-(1-benzofuran-4-ylmethyl)-8-(4-methylsulfonylphenyl)-6~{H}-[1,2,4]triazolo[4,3-c]pyrimidin-5-imine | L9K |
 |
1 |
| 392 | (1S)-2-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-1-[(octadecanoyloxy)methyl]ethyl (9Z)-octadec-9-enoate | L9Q |
 |
1 |
| 393 | L-DOPAMINE | LDP |
 |
1 |
| 394 | (7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL | MOI |
 |
1 |
| 395 | 1-(4-methoxyphenyl)-6-(4-(1-(pyrrolidin-1-ylmethyl)cyclopropyl)phenyl)-3-(trifluoromethyl)-5,6-dihydro-1H-pyrazolo[3,4-c]pyridin-7(4H)-one | LG0 |
 |
1 |
| 396 | 1,3-dihydroimidazole-2-thione | MZY |
 |
1 |
| 397 | N-(3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE | LGJ |
 |
1 |
| 398 | 6-(2'-(METHYLSULFONYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE | LGK |
 |
1 |
| 399 | 1-(3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-6-(2'-(PYRROLIDIN-1-YLMETHYL)BIPHENYL-4-YL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE | LGL |
 |
1 |
| 400 | (2~{S})-~{N}-[3-oxidanylidene-3-[(3,4,5-trimethoxyphenyl)amino]propyl]-1-(phenylmethyl)sulfonyl-piperidine-2-carboxamide | LL7 |
 |
1 |